Apimeds Ev To Operating Cash Flow from 2010 to 2026
| APUS Stock | 1.56 0.06 3.70% |
EV To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter (31.84) | Current Value (33.43) | Quarterly Volatility 6.72058003 |
Check Apimeds Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apimeds Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 142.1 K, Selling General Administrative of 749.4 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Apimeds financial statements analysis is a perfect complement when working with Apimeds Pharmaceuticals Valuation or Volatility modules.
Apimeds | Ev To Operating Cash Flow | Build AI portfolio with Apimeds Stock |
The evolution of Ev To Operating Cash Flow for Apimeds Pharmaceuticals US provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Apimeds Pharmaceuticals compares to historical norms and industry peers.
Latest Apimeds Pharmaceuticals' Ev To Operating Cash Flow Growth Pattern
Below is the plot of the Ev To Operating Cash Flow of Apimeds Pharmaceuticals US over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Apimeds Pharmaceuticals' EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apimeds Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Ev To Operating Cash Flow | 10 Years Trend |
|
Ev To Operating Cash Flow |
| Timeline |
Apimeds Ev To Operating Cash Flow Regression Statistics
| Arithmetic Mean | (33.64) | |
| Coefficient Of Variation | (19.98) | |
| Mean Deviation | 3.84 | |
| Median | (31.09) | |
| Standard Deviation | 6.72 | |
| Sample Variance | 45.17 | |
| Range | 26.9567 | |
| R-Value | (0.37) | |
| Mean Square Error | 41.44 | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | (0.50) | |
| Total Sum of Squares | 722.66 |
Apimeds Ev To Operating Cash Flow History
About Apimeds Pharmaceuticals Financial Statements
Apimeds Pharmaceuticals shareholders use historical fundamental indicators, such as Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Apimeds Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Apimeds Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Apimeds Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| EV To Operating Cash Flow | (31.84) | (33.43) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.